[1] Univ Chicago, Dept Med, Chicago, IL USA
[2] Fdn IRCCS Ist Nazl Tumori INT, Dept Prevent & Predict Med, Unit Mol Bases Genet Risk & Genet Testing, Milan, Italy
[3] IDIS, CIBERER, Grp Med Xenom USC, Fdn Publ Galega Med Xenom SERGAS, Santiago De Compostela, Spain
[4] Univ Cologne, Med Fac, Ctr Hereditary Breast & Ovarian Canc, CIO, Cologne, Germany
[5] Univ Cologne, CMMC, Cologne, Germany
[6] Univ Hosp Cologne, Cologne, Germany
[7] Inst Curie, Serv Genet, Paris, France
[8] Inst Curie, INSERM U830, Paris, France
[9] Univ Paris 05, Sorbonne Paris Cite, Paris, France
[10] Univ Otago, Dept Pathol, Christchurch, New Zealand
[11] Hosp Clin San Carlos, Inst Invest Sanitaria San Carlos IdISSC, Lab Oncol Mol, Madrid, Spain
[12] Odense Univ Hosp, Dept Clin Genet, Odense C, Denmark
[13] QIMR Berghofer Med Res Inst, Genet & Computat Biol Div, Brisbane, Qld, Australia
[14] Maastricht Univ, Dept Clin Genet, Med Ctr, Maastricht, Netherlands
[15] Maastricht Univ, Fac Humanities & Sci, Maastricht Sci Programme, Maastricht, Netherlands
[16] Univ Southampton, Human Dev & Hlth Acad Unit, Southampton Gen Hosp, Fac Med, Southampton, Hants, England
[17] VHIO, Oncogenet Grp, Barcelona, Spain
[18] Univ Autonoma Barcelona, Barcelona, Spain
[19] Univ Hosp Vall dHebron, Clin & Mol Genet Area, Barcelona, Spain
[20] IDIBELL Catalan Inst Oncol, Hereditary Canc Program, Mol Diagnost Unit, Barcelona, Spain
[21] Peter MacCallum Canc Ctr, East Melbourne, Vic, Australia